Journal of Commercial Biotechnology

Current Issue

Vol 25 No 1
Published November 20, 2019

Commentary

Amanda Maxham, Henry I. Miller
USDA Reorganization Should Reduce Biotech Regulation and Feds’ Involvement in the Organic Industry
https://doi.org/10.5912/jcb870
Requires Subscription or Fee PDF

Articles

Christopher C Lamb
How Should Start-Up Biotechnology Companies Manage Learning and Generate the Necessary Knowledge to Achieve an Alliance-Based Stage of Growth
https://doi.org/10.5912/jcb878
Requires Subscription or Fee PDF
Javier Saladich Nebot
Patents and Diagnostic Methods in the U.S.: The Subject Matter Eligibility Trap
https://doi.org/10.5912/jcb876
Requires Subscription or Fee PDF
Robert Beach
Valuing Carryforwards for the Small Cap Biotechnology Subindustry
https://doi.org/10.5912/jcb874
Requires Subscription or Fee PDF

Intellectual Property Management

Sujit J Patil, Swapnil L Bhalke, Nishad Deshpande
A state of the art in genetic improvement of Asparagus plants: Patent based perspective.
https://doi.org/10.5912/jcb864
Requires Subscription or Fee PDF

Case Study

Lucie Perrier
Accessing Continuous Glucose Monitoring (CGM) Sensors in France and the US: A Comparative Case Study of Abbott’s FreeStyle Libre (FSL) System
https://doi.org/10.5912/jcb873
Requires Subscription or Fee PDF
View All Issues